SMT's Supraflex Cruz Coronary Stent Receives Regulatory Approval in Canada
Sep 09, 2026
Mumbai (Maharashtra) [India], September 9: Sahajanand Medical Technologies Limited (SMT) has received a Class IV medical device license from Health Canada’s Medical Devices Directorate for its Supraflex Cruz sirolimus-eluting coronary stent system, marking the company’s entry into a new North American market.
Read More...